Darius Bilimoria

728 total citations
11 papers, 472 citations indexed

About

Darius Bilimoria is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Darius Bilimoria has authored 11 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Darius Bilimoria's work include Hepatitis C virus research (8 papers), HIV/AIDS drug development and treatment (6 papers) and Hepatitis B Virus Studies (3 papers). Darius Bilimoria is often cited by papers focused on Hepatitis C virus research (8 papers), HIV/AIDS drug development and treatment (6 papers) and Hepatitis B Virus Studies (3 papers). Darius Bilimoria collaborates with scholars based in Canada, United States and France. Darius Bilimoria's co-authors include Constantin G. Yannopoulos, Laval Chan, Jean Bédard, M.M. Cherney, B.K. Biswal, Olivier Nicolas, Michael N.G. James, Meitian Wang, Lucille L’Heureux and Sanjoy Das and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Journal of Virology.

In The Last Decade

Darius Bilimoria

11 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darius Bilimoria Canada 10 320 220 171 161 88 11 472
Constantin G. Yannopoulos Canada 11 431 1.3× 290 1.3× 229 1.3× 286 1.8× 107 1.2× 12 732
Djadé I. Soumana United States 8 243 0.8× 200 0.9× 150 0.9× 137 0.9× 61 0.7× 8 441
Karen Rigat United States 10 363 1.1× 193 0.9× 262 1.5× 115 0.7× 25 0.3× 13 511
Lucille L’Heureux Canada 9 164 0.5× 169 0.8× 94 0.5× 112 0.7× 61 0.7× 9 327
Nancy Butkiewicz United States 14 221 0.7× 118 0.5× 148 0.9× 131 0.8× 26 0.3× 24 409
Carrie A. Rutkowski United States 11 200 0.6× 295 1.3× 138 0.8× 196 1.2× 27 0.3× 13 518
Monica Bisbocci Italy 7 222 0.7× 148 0.7× 165 1.0× 106 0.7× 16 0.2× 10 336
Megan H. Powdrill Canada 10 187 0.6× 138 0.6× 157 0.9× 165 1.0× 14 0.2× 18 407
Laura M. Deveau United States 6 141 0.4× 96 0.4× 86 0.5× 199 1.2× 32 0.4× 9 372
Nghe Nguyen‐Ba Canada 16 297 0.9× 600 2.7× 266 1.6× 358 2.2× 59 0.7× 25 977

Countries citing papers authored by Darius Bilimoria

Since Specialization
Citations

This map shows the geographic impact of Darius Bilimoria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darius Bilimoria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darius Bilimoria more than expected).

Fields of papers citing papers by Darius Bilimoria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darius Bilimoria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darius Bilimoria. The network helps show where Darius Bilimoria may publish in the future.

Co-authorship network of co-authors of Darius Bilimoria

This figure shows the co-authorship network connecting the top 25 collaborators of Darius Bilimoria. A scholar is included among the top collaborators of Darius Bilimoria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darius Bilimoria. Darius Bilimoria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Goulet, Marie-Line, Shauna Dauphinee, Kristine S. Louis, et al.. (2024). Abstract PR006: EG-70 (detalimogene voraplasmid), a novel, non-viral intravesical gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: Preclinical characterization and translation into the clinic. Clinical Cancer Research. 30(10_Supplement). PR006–PR006. 1 indexed citations
2.
3.
Li, Pan, Warren A. Dorsch, Darius Bilimoria, et al.. (2017). Discovery of Novel Allosteric HCV NS5B Inhibitors. 2. Lactam-Containing Thiophene Carboxylates. ACS Medicinal Chemistry Letters. 8(2). 251–255. 9 indexed citations
4.
Bédard, Jean, et al.. (2009). 935 IDENTIFICATION AND CHARACTERIZATION OF VCH-222, A NOVEL POTENT AND SELECTIVE NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR. Journal of Hepatology. 50. S340–S340. 13 indexed citations
5.
Corbeil, Christopher R., Pablo Englebienne, Constantin G. Yannopoulos, et al.. (2008). Docking Ligands into Flexible and Solvated Macromolecules. 2. Development and Application of Fitted 1.5 to the Virtual Screening of Potential HCV Polymerase Inhibitors. Journal of Chemical Information and Modeling. 48(4). 902–909. 46 indexed citations
6.
Biswal, B.K., Meitian Wang, M.M. Cherney, et al.. (2006). Non-nucleoside Inhibitors Binding to Hepatitis C Virus NS5B Polymerase Reveal a Novel Mechanism of Inhibition. Journal of Molecular Biology. 361(1). 33–45. 61 indexed citations
7.
Biswal, B.K., M.M. Cherney, Meitian Wang, et al.. (2005). Crystal Structures of the RNA-dependent RNA Polymerase Genotype 2a of Hepatitis C Virus Reveal Two Conformations and Suggest Mechanisms of Inhibition by Non-nucleoside Inhibitors. Journal of Biological Chemistry. 280(18). 18202–18210. 152 indexed citations
8.
Chan, Leunglung, Sanjoy K. Das, Mélanie Proulx, et al.. (2004). Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: Tertiary amides. Bioorganic & Medicinal Chemistry Letters. 14(3). 797–800. 84 indexed citations
9.
Reddy, T. Jagadeeswar, Laval Chan, Mélanie Proulx, et al.. (2003). Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 13(19). 3341–3344. 12 indexed citations
10.
Chan, Laval, T. Jagadeeswar Reddy, Mélanie Proulx, et al.. (2003). Identification of N,N-Disubstituted Phenylalanines as a Novel Class of Inhibitors of Hepatitis C NS5B Polymerase. Journal of Medicinal Chemistry. 46(8). 1283–1285. 59 indexed citations
11.
Hamel, Martine, Lucille L’Heureux, Olivier Nicolas, et al.. (2001). The hepatitis C virus NS5B RNA-dependent RNA polymerase activity and susceptibility to inhibitors is modulated by metal cations.. PubMed. 3(6). 306–16. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026